WallStSmart

Covista Inc. (CVSA)vsGraham Holdings Co (GHC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Graham Holdings Co generates 160% more annual revenue ($4.91B vs $1.89B). CVSA leads profitability with a 13.4% profit margin vs 6.0%. CVSA appears more attractively valued with a PEG of 0.81. CVSA earns a higher WallStSmart Score of 67/100 (B-).

CVSA

Strong Buy

67

out of 100

Grade: B-

Growth: 5.3Profit: 7.5Value: 8.3Quality: 5.0

GHC

Buy

51

out of 100

Grade: C-

Growth: 6.0Profit: 4.5Value: 4.7Quality: 7.5
Piotroski: 4/9Altman Z: 3.27
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CVSASignificantly Overvalued (N/A)

Margin of Safety

N/A

Fair Value

$97.23

Current Price

$106.98

$9.75 premium

UndervaluedFair: $97.23Overvalued
GHCSignificantly Overvalued (-145.2%)

Margin of Safety

-145.2%

Fair Value

$452.27

Current Price

$1036.87

$584.60 premium

UndervaluedFair: $452.27Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CVSA4 strengths · Avg: 8.0/10
PEG RatioValuation
0.818/10

Growing faster than its price suggests

P/E RatioValuation
15.8x8/10

Attractively priced relative to earnings

Price/BookValuation
2.7x8/10

Reasonable price relative to book value

Operating MarginProfitability
22.9%8/10

Strong operational efficiency at 22.9%

GHC5 strengths · Avg: 9.4/10
Price/BookValuation
0.9x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
40.0%10/10

Revenue surging 40.0% year-over-year

Altman Z-ScoreHealth
3.2710/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.269/10

Conservative balance sheet, low leverage

P/E RatioValuation
16.2x8/10

Attractively priced relative to earnings

Areas to Watch

CVSA1 concerns · Avg: 4.0/10
EPS GrowthGrowth
4.7%4/10

4.7% earnings growth

GHC4 concerns · Avg: 2.5/10
Return on EquityProfitability
6.5%3/10

ROE of 6.5% — below average capital efficiency

Profit MarginProfitability
6.0%3/10

6.0% margin — thin

PEG RatioValuation
4.042/10

Expensive relative to growth rate

EPS GrowthGrowth
-80.1%2/10

Earnings declined 80.1%

Comparative Analysis Report

WallStSmart Research

Bull Case : CVSA

The strongest argument for CVSA centers on PEG Ratio, P/E Ratio, Price/Book. Revenue growth of 12.4% demonstrates continued momentum. PEG of 0.81 suggests the stock is reasonably priced for its growth.

Bull Case : GHC

The strongest argument for GHC centers on Price/Book, Revenue Growth, Altman Z-Score. Revenue growth of 40.0% demonstrates continued momentum.

Bear Case : CVSA

The primary concerns for CVSA are EPS Growth.

Bear Case : GHC

The primary concerns for GHC are Return on Equity, Profit Margin, PEG Ratio.

Key Dynamics to Monitor

CVSA profiles as a value stock while GHC is a hypergrowth play — different risk/reward profiles.

GHC carries more volatility with a beta of 0.81 — expect wider price swings.

GHC is growing revenue faster at 40.0% — sustainability is the question.

CVSA generates stronger free cash flow (15M), providing more financial flexibility.

Bottom Line

CVSA scores higher overall (67/100 vs 51/100) and 12.4% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Covista Inc.

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Covista Inc., provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. The company is headquartered in Chicago, Illinois.

Graham Holdings Co

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Graham Holdings Company is a diversified global media and education company. The company is headquartered in Arlington, Virginia.

Visit Website →

Want to dig deeper into these stocks?